Results
1 -
10 of
47
(Click
here to explore results)
- CDK9 inhibitors in cancer research. Zhi Huang, Tianqi Wang, Cheng Wang, Yan Fan
, RSC Med. Chem.
, 2022
, 13
, 688
- Natural products as kinase inhibitors. Jing Liu, Yi Hu, David L. Waller, Junfeng Wang, Qingsong Liu
, Nat. Prod. Rep.
, 2012
, 29
, 392
- Small hybrid heteroaromatics: resourceful biological tools in cancer research. Vikrant Abbot, Poonam Sharma, Saurabh Dhiman, Malleshappa N. Noolvi, Harun M. Patel, Varun Bhardwaj
, RSC Adv.
, 2017
, 7
, 28313
- Transformations of the natural cytokinin N6-isopentenyladenine in aqueous acidic media: structural aspects. Zdeněk Trávníček, Radka Novotná, Jaromír Marek, Igor Popa, Michal Šipl
, Org. Biomol. Chem.
, 2011
, 9
, 5703
- Identification of the cellular targets of bioactive small organic molecules using affinity reagents. Benjamin J. Leslie, Paul J. Hergenrother
, Chem. Soc. Rev.
, 2008
, 37
, 1347
- Inhibitors of transcription factor nuclear factor-kappa beta (NF-κβ)-DNA binding. Rakesh Kumar Sharma, Masami Otsuka, Garima Gaba, Shilpa Mehta
, RSC Adv.
, 2013
, 3
, 1282
- Genomics and the second golden era of cancer drug development. Paul Workman
, Mol. BioSyst.
, 2005
, 1
, 17
- Research progress of anticancer drugs targeting CDK12. Zhijia Yan, Yongli Du, Haibin Zhang, Yong Zheng, Huiting Lv, Ning Dong, Fang He
, RSC Med. Chem.
, 2023
, 14
, 1629
- Novel tacrine derivatives as potential CDK9 inhibitors with low cholinesterase inhibitory properties: design, synthesis, and biological evaluation. Wenwu Liu, Yaoguang Huang, Limeng Wu, Wenjie Liu, Xiaowen Jiang, Zihua Xu, Qingchun Zhao
, New J. Chem.
, 2022
, 46
, 19342
- The right tools for the job: the central role for next generation chemical probes and chemistry-based target deconvolution methods in phenotypic drug discovery. Manuela Jörg, Katrina S. Madden
, RSC Med. Chem.
, 2021
, 12
, 646